Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Pak J Pharm Sci ; 34(5(Supplementary)): 1879-1884, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-34836854

RESUMEN

The present study was designed to evaluate the antipyretic and antinociceptive activities of R. communis leaves and W. somnifera roots hydroalcoholic extracts in Wistar rats. To assess the antipyretic activity, Brewer's yeast suspension was used to induce hyperthermia. Antinociceptive activity was observed using acetic acid-induced abdominal writhing, formalin-induced paw licking reflex and heat-induced pain models. R. communis and W. somnifera extracts were used at 150, 250 and 500mg/kg. Results showed that administration of both plants significantly (p<0.001) lowered rectal temperature (°C) in a dose-dependent manner from 1h to 4h of study. R. communis and W. somnifera extracts showed a dose-dependent reduction in abdominal writhing induced by acetic acid and decreased the paw licking reflex in formalin-induced nociceptive response. In the heat test, R. communis and W. somnifera extracts exhibited significant (p<0.001) analgesic effects evidenced as an increase in latency time. However, R. communis exhibited prominent antipyretic and antinociceptive activities at 250 and 500mg/kg as compared to W. somnifera. Conclusively, R. communis and W. somnifera could be a potential source of antipyretic and analgesic agents which require further studies.


Asunto(s)
Analgésicos/farmacología , Antipiréticos/farmacología , Extractos Vegetales/farmacología , Ricinus/química , Withania/química , Animales , Temperatura Corporal/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Femenino , Hipertermia/inducido químicamente , Hipertermia/tratamiento farmacológico , Dimensión del Dolor/efectos de los fármacos , Raíces de Plantas/química , Ratas , Ratas Wistar , Saccharomyces cerevisiae
3.
IEEE J Biomed Health Inform ; 27(2): 778-789, 2023 02.
Artículo en Inglés | MEDLINE | ID: mdl-35696470

RESUMEN

Recent advances in electronic devices and communication infrastructure have revolutionized the traditional healthcare system into a smart healthcare system by using internet of medical things (IoMT) devices. However, due to the centralized training approach of artificial intelligence (AI), mobile and wearable IoMT devices raise privacy issues concerning the information communicated between hospitals and end-users. The information conveyed by the IoMT devices is highly confidential and can be exposed to adversaries. In this regard, federated learning (FL), a distributive AI paradigm, has opened up new opportunities for privacy preservation in IoMT without accessing the confidential data of the participants. Further, FL provides privacy to end-users as only gradients are shared during training. For these specific properties of FL, in this paper, we present privacy-related issues in IoMT. Afterwards, we present the role of FL in IoMT networks for privacy preservation and introduce some advanced FL architectures by incorporating deep reinforcement learning (DRL), digital twin, and generative adversarial networks (GANs) for detecting privacy threats. Moreover, we present some practical opportunities for FL in IoMT. In the end, we conclude this survey by discussing open research issues and challenges while using FL in future smart healthcare systems.


Asunto(s)
Inteligencia Artificial , Privacidad , Humanos , Comunicación , Electrónica , Hospitales
4.
Diagnostics (Basel) ; 13(15)2023 Jul 31.
Artículo en Inglés | MEDLINE | ID: mdl-37568904

RESUMEN

AIM OF THE STUDY: To draw inferences from a retrospective evaluation of PSMA PET CT scans performed for the evaluation of biochemical recurrence. MATERIAL AND METHODS: A retrospective analysis of 295 PSMA PET CT scans spanning 3 years between 2020 and 2022 was undertaken. RESULTS: Of 295 PET CT scans, 179 were positive, 66 were negative and 50 had indeterminate findings. In the positive group, 67 had radical prostatectomy and PSMA avid lesions were seen most commonly in pelvic lymph nodes. The remaining 112 positive scans were in the non-radical prostatectomy group; 25 had recurrence only in the prostate, 17 had recurrence involving the prostate bed; 28 had no recurrence in the prostate gland, while 42 had recurrence in the prostate as well as in extra-prostatic sites. Overall, in the non-prostatectomy group, 75% of the population was harboring a PSMA avid lesion in the prostate gland while in the remaining 25% of the population, recurrence did not involve the prostate gland. The majority of indeterminate findings were seen in small pelvic or retroperitoneal lymph nodes or skeletal regions (ribs/others) and in nine patients indeterminate focus was seen in the prostate bed only. Follow-up PSMA PET CT was helpful in prior indeterminate findings and unexplained PSA rise. CONCLUSION: A higher recurrence in the prostate bed while evaluating biochemical recurrence prompts the following: question: should prostatectomy be offered more proactively? Follow-up PSMA PET CT is helpful for indeterminate findings; a PSA rise of 0.7 ng/mL in 6 months can result in positive PSMA PET CT while negative scans can be seen up to a 2 ng/mL PSA rise in 6 months.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA